Business
Steriwave Standard of Care in 2nd Health Authority
Steriwave Standard of Care in 2nd Health Authority.
About this update from Ondine Biomedical, Inc.
[{"type":"text","content":"\n\n25 June 2025\nONDINE BIOMEDICAL INC.\n(\"Ondine Biomedical\", \"Ondine\" or the \"Company\")\n \nSteriwave Standard of Care in 2nd Health Authority\nBritish Columbia's Interior Health is Second Provincial Health Authority in Canada to Standardize Steriwave® for All Total Hip and Knee Arthroplasty Surgeries\nOndine Biomedical Inc. (AIM: OBI) announces that, with the implementation at Vernon Jubilee Hospital, British Columbia's Interior Health Authority (IHA) has completed the rollout of Steriwave® nasal decolonization therapy for all total hip and knee replacement surgeries. With this implementation, IHA becomes the second provincial health authority in Canada to adopt Steriwave as standard of care for these procedures.\nSteriwave is now in use at 17 hospitals across all five health authorities in British Columbia (BC), which collectively serve most of the province's 5.7 million residents. Steriwave is also standard of care in six of Canada's top ten largest hospitals and in several UK private sector and NHS trust hospitals.\nVancouver Coastal Health (VCH) was the first Canadian Health Authority to adopt Steriwave as standard of care for major surgeries. The movement toward standardized use of Steriwave began at Vancouver Coastal Health Authority's Vancouver General Hospital (VGH) and University of British Columbia (UBC) Hospitals. Under the leadership of Drs. Elizabeth Bryce, Titus Wong, Diane Roscoe, and Bas Masri, these institutions became the first in the world to implement universal pre-surgical nasal photodisinfection for major surgeries. Their work demonstrated sustained infection rate reductions exceeding 50% over more than a decade without generating antimicrobial resistance. The VGH/UBC team was recognized with several awards including the 2013 International Consortium for Prevention and Infection Control Innovation Excellence Award in Geneva, becoming the first Canadians to receive this global award.\nSubsequent data from VGH's spine team, led by Dr. John Street, showed that the use of Steriwave in spine surgery patients reduced post-surgical infection rates by 66.5% and delivered nearly CA$2,600 in cost savings per patient amounting to CA$2.5 million in annual savings for the hospital's spine program.[[1]]\nThese VCH results laid the groundwork for broader adoption across BC and abroad, including Mid Yorkshir...